...
首页> 外文期刊>Current opinion in HIV and AIDS >Unique features of memory T cells in HIV elite controllers: a systems biology perspective.
【24h】

Unique features of memory T cells in HIV elite controllers: a systems biology perspective.

机译:HIV精英控制者中记忆T细胞的独特特征:系统生物学的观点。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE OF REVIEW: Elite controllers constitute a rare group of HIV-infected individuals who control HIV replication and maintain normal CD4 cell counts without antiretroviral therapy (ART). The mechanisms involved in the control of infection are poorly understood. This review will focus on the identification of signaling pathways upregulated or downregulated in different memory T-cell subsets in elite controllers by using systems biology approaches. Features of memory T cells in simian immunodeficiency virus (SIV) natural hosts will be also highlighted. Finally, we will discuss how these approaches will guide the development of new vaccines and therapeutic interventions. RECENT FINDINGS: Studies by our group identified the FOXO3a, STAT5, and Wnt/beta-catenin pathways as unique molecular signatures associated with survival of memory T cells in elite controllers. These discoveries open the path for the design of new strategies to prevent T-cell depletion in HIV-infected individuals. SUMMARY: The use of systems biology to identify molecular pathways involved in the survival of memory T cells is a powerful tool toward the understanding of mechanisms of HIV control in elite controllers. This will help to identify correlates of immune protection leading to the design of effective HIV vaccines and new targeted therapeutic interventions.
机译:审查目的:精英控制者是一类罕见的被HIV感染者,可以控制HIV复制并在不进行抗逆转录病毒疗法(ART)的情况下维持正常的CD4细胞计数。对感染控制的机制了解甚少。这篇综述将着重于通过使用系统生物学方法来识别精英控制器中不同记忆T细胞亚群中上调或下调的信号通路。猿猴免疫缺陷病毒(SIV)天然宿主中记忆T细胞的特征也将突出显示。最后,我们将讨论这些方法如何指导新疫苗和治疗性干预措施的开发。最近的发现:我们小组的研究确定了FOXO3a,STAT5和Wnt /β-catenin途径是与精英控制者中记忆T细胞存活相关的独特分子标记。这些发现为预防艾滋病毒感染者中T细胞耗竭的新策略的设计开辟了道路。摘要:使用系统生物学来识别参与记忆T细胞存活的分子途径是了解精英控制者中HIV控制机制的有力工具。这将有助于鉴定免疫保护的相关性,从而导致设计有效的HIV疫苗和新的靶向治疗干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号